EP4077639

AÐFERÐ TIL MYNDUNAR Á ÓNÆMISSTILLANDI FRUMUM Í BLÓÐAFLEIDDU SÝNI

  • Status:
    EP einkaleyfi í gildi á Íslandi
  • EP appl. date:
    17.12.2020
  • EP published:
    12.6.2024
  • EP application number:
    20833822.8
  • Max expiry date:
    16.12.2040
  • Expiry date:
    16.12.2026
  • Next due date:
    31.12.2026
  • Title in English:
    METHOD FOR GENERATING IMMUNOREGULATORY CELLS IN A BLOOD-DERIVED SAMPLE
  • Language of the patent:
    English

Timeline

Today
17.12.2020EP application
12.6.2024EP Publication
9.8.2024Translation submitted
15.9.2024Registration published
16.12.2026Expires

Owner

  • Name:
    THERAKOS DEVELOPMENT LIMITED
  • Address:
    c/o TMF Group Ground Floor Two Dockland Central Guild Street, North Dock Dublin 1 D01 K2C5, IE

Inventor

  • Name:
    ZEISER, Robert
  • Address:
    79100 Freiburg, DE
  • Name:
    APOSTOLOVA, Petya
  • Address:
    79106 Freiburg, DE
  • Name:
    DUYSTER, Justus
  • Address:
    79106 Freiburg, DE

Agent

  • Name:
    G.H. Sigurgeirsson ehf.
  • Address:
    Borgartúni 26, 105, Reykjavík,

Priority

  • Number:
    19218724
  • Date:
    20.12.2019
  • Country:
    EP

Classification

  • Categories:
    C12N 5/0783, A61K 41/00

Annual fees

Number

Paid

Expires

Payer

Number: 5

Paid: 10.12.2024

Expires: 16.12.2025

Payer: G.H. Sigurgeirsson ehf.

Number: 6

Paid: 15.12.2025

Expires: 16.12.2026

Payer: Árnason Faktor ehf.

Upload documents